Jozef Madzo to Azacitidine
This is a "connection" page, showing publications Jozef Madzo has written about Azacitidine.
Connection Strength
0.173
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.120
-
Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors. Surgery. 2023 04; 173(4):1045-1051.
Score: 0.053